Corden Pharma International GmbH Sustainability Profile
Corden Pharma International GmbH, a leading contract development and manufacturing organisation (CDMO), is headquartered in Germany and operates across Europe and North America. Founded in 2006, the company has established itself in the pharmaceutical and biotechnology sectors, specialising in the development and production of complex drug formulations, including injectables and oral solid dosage forms. Corden Pharma is renowned for its comprehensive range of services, from early-stage development to commercial manufacturing, with a strong emphasis on quality and regulatory compliance. The company’s unique capabilities in custom synthesis and formulation development set it apart in a competitive market. With a commitment to innovation and excellence, Corden Pharma has achieved significant milestones, positioning itself as a trusted partner for clients seeking reliable and efficient solutions in the pharmaceutical landscape.
DitchCarbon Score
How does Corden Pharma International GmbH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Corden Pharma International GmbH's score of 20 is lower than 76% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Corden Pharma International GmbH's reported carbon emissions
Corden Pharma International GmbH, headquartered in Germany, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Corden Pharma may not have established formal commitments to reduce its carbon footprint or may not publicly disclose such information. In the context of the pharmaceutical industry, many companies are increasingly focusing on sustainability and climate action, often setting science-based targets to align with global climate goals. However, without specific emissions data or commitments from Corden Pharma, it is unclear how the company is addressing its environmental impact or contributing to broader industry efforts in climate change mitigation.
How Carbon Intensive is Corden Pharma International GmbH's Industry?
How Carbon Intensive is Corden Pharma International GmbH's Location?
Corden Pharma International GmbH's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Corden Pharma International GmbH has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
